Vaccine + Durvalumab in Human Papilloma Virus (HPV) Cancers
Conditions: Malignant Neoplasms of Digestive Organs; Malignant Neoplasms of Female Genital Organs; Malignant Neoplasms of Male Genital Organs; Human Papilloma Virus Interventions: Biological: MEDI0457; Drug: Durvalumab; Procedure: Electroporation Sponsors: M.D. Anderson Cancer Center; AstraZeneca; Inovio Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AstraZeneca | Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer Vaccine | Human Papillomavirus (HPV) | Vaccines